Varian introduces HPLC columns for R&D applications
use in the pharmaceutical industry, particularly in pre-clinical
development, increasing productivity by enabling more products to
be purified in less time.
High performance liquid chromatography (HPLC) has become the mainstay for drug R&D, having developed into an effective technique that has evolved into different types to satisfy the numerous processes.
The Pursuit XRs Prep columns, an extension of its Pursuit XRs line of HPLC columns, provide fast, high-resolution separations and allows for the highest available mass loading.
Combining high ligand density with 5 and 10 micron, 100 angstrom high surface area silica, Pursuit XRs Prep columns offer increased sample loadability and column stability.
Compared to currently available products, Pursuit XRs Prep columns claim to enable up to 2.5 times more material to be purified per run.
The columns are available with both C18 and silica phases with bulk media also available. Both preparative columns and bulk media can be ordered for immediate shipment.
"With the introduction of the Pursuit XRs Prep columns, pre-clinical researchers can more quickly obtain large amounts of high-purity product," said Martin O'Donoghue, senior vice president, Scientific Instruments, Varian.
"The addition of preparative columns and self-packing capability to the Pursuit XRs product line gives our customers more options to improve their productivity and reduce operating costs."
With worldwide revenues estimated at over $2.5bn (€1.9bn) annually, HPLC continues to dominate the analytical instrument industry, and hyphenated techniques such as LC/MS and LC/MS/MS are growing at a phenomenal rate.
Driven by the booming life sciences market, LC/MS sales are expected to continue soaring at double-digit growth rates as the technique gains wider acceptance.
